Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Crown

Showing results (101-110 of 188) with videos related to

Pageof 19
Sort By:
The Lancet. Oncology|December 11, 2002
Chemotherapy for metastatic breast cancer-report of a European expert panelJohn Crown, Véronique Diéras, Manfred Kaufmann, et al.
Cancers|December 2, 2020
Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate CancerR William Watson, Haleema Azam, Claudia Aura, et al.
Plos One|December 20, 2012
Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomesClaire Corcoran, Sweta Rani, Keith O'Brien, et al.
Rare Tumors|December 1, 2025
Spontaneous regression of metastatic disease after palliative debulking surgery for heavily pre-treated extraskeletal myxoid chondrosarcoma: A case reportHailey Kathryn Carroll, Anna Keogh, Simon Barry, et al.
Investigational New Drugs|October 14, 2020
The novel low molecular weight MYC antagonist MYCMI-6 inhibits proliferation and induces apoptosis in breast cancer cellsDalal AlSultan, Emma Kavanagh, Shane O'Grady, et al.
Investigational New Drugs|February 4, 2018
The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cellsAlexandra Canonici, Zulfiqar Qadir, Neil T Conlon, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2013
Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cellsKeith O'Brien, Sweta Rani, Claire Corcoran, et al.
Molecular Cancer|October 26, 2014
OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasetsStephen F Madden, Colin Clarke, Britta Stordal, et al.
Medical Sciences (Basel, Switzerland)|June 23, 2022
Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma SubtypesCharlotte Andrieu, Niamh McNamee, Anne-Marie Larkin, et al.
Cancers|February 13, 2019
HER2-Targeted Tyrosine Kinase Inhibitors Cause Therapy-Induced-Senescence in Breast Cancer CellsMartina S J McDermott, Neil Conlon, Brigid C Browne, et al.
Pageof 19

Showing results (101-110 of 188) with videos related to

Sort By:
Pageof 19
The Lancet. Oncology|December 11, 2002
Chemotherapy for metastatic breast cancer-report of a European expert panelJohn Crown, Véronique Diéras, Manfred Kaufmann, et al.
Cancers|December 2, 2020
Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate CancerR William Watson, Haleema Azam, Claudia Aura, et al.
Plos One|December 20, 2012
Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomesClaire Corcoran, Sweta Rani, Keith O'Brien, et al.
Rare Tumors|December 1, 2025
Spontaneous regression of metastatic disease after palliative debulking surgery for heavily pre-treated extraskeletal myxoid chondrosarcoma: A case reportHailey Kathryn Carroll, Anna Keogh, Simon Barry, et al.
Investigational New Drugs|October 14, 2020
The novel low molecular weight MYC antagonist MYCMI-6 inhibits proliferation and induces apoptosis in breast cancer cellsDalal AlSultan, Emma Kavanagh, Shane O'Grady, et al.
Investigational New Drugs|February 4, 2018
The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cellsAlexandra Canonici, Zulfiqar Qadir, Neil T Conlon, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2013
Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cellsKeith O'Brien, Sweta Rani, Claire Corcoran, et al.
Molecular Cancer|October 26, 2014
OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasetsStephen F Madden, Colin Clarke, Britta Stordal, et al.
Medical Sciences (Basel, Switzerland)|June 23, 2022
Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma SubtypesCharlotte Andrieu, Niamh McNamee, Anne-Marie Larkin, et al.
Cancers|February 13, 2019
HER2-Targeted Tyrosine Kinase Inhibitors Cause Therapy-Induced-Senescence in Breast Cancer CellsMartina S J McDermott, Neil Conlon, Brigid C Browne, et al.
Pageof 19